Glaucoma
Conditions
Brief summary
The investigators aim to evaluate the efficacy of the new Optical Coherence Tomography based Angiography (OCT-A) softwares in the diagnosis and management of glaucoma.
Interventions
DEVICEOptical Coherence Tomography based Angiography
A contrast-free, noninvasive technology to identify blood vessels in the eye
Sponsors
Swiss Vision Network
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosis of open angle glaucoma (OAG) including pseudo-exfoliative and pigmentary glaucoma. * Documented glaucomatous visual field damage (in the previous 12 months with mean defect (MD) \> 2.0 dB) * Structural and/or functional glaucomatous damage * Have given written informed consent, prior to any investigational procedures
Exclusion criteria
* Patients with allergy to corneal anesthetic * Patients not able to understand the character and individual consequences of the investigation * Participation in other clinical research within the last 4 weeks * Other diseases that may cause visual field loss or optic disc abnormalities * Refractive error of \> +3.00D or \< -7.00D
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Macular and optic nerve head bloodflow, as measured by OCT-A macular and optic nerve head vessel density (%) | Up to 3 years |
Countries
Switzerland
Outcome results
None listed